356 related articles for article (PubMed ID: 31297187)
1. Recent advances in celiac disease and refractory celiac disease.
Malamut G; Cording S; Cerf-Bensussan N
F1000Res; 2019; 8():. PubMed ID: 31297187
[TBL] [Abstract][Full Text] [Related]
2. Progression of Celiac Disease in Children With Antibodies Against Tissue Transglutaminase and Normal Duodenal Architecture.
Auricchio R; Mandile R; Del Vecchio MR; Scapaticci S; Galatola M; Maglio M; Discepolo V; Miele E; Cielo D; Troncone R; Greco L
Gastroenterology; 2019 Aug; 157(2):413-420.e3. PubMed ID: 30978358
[TBL] [Abstract][Full Text] [Related]
3. Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease.
Croese J; Giacomin P; Navarro S; Clouston A; McCann L; Dougall A; Ferreira I; Susianto A; O'Rourke P; Howlett M; McCarthy J; Engwerda C; Jones D; Loukas A
J Allergy Clin Immunol; 2015 Feb; 135(2):508-16. PubMed ID: 25248819
[TBL] [Abstract][Full Text] [Related]
4. AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review.
Green PHR; Paski S; Ko CW; Rubio-Tapia A
Gastroenterology; 2022 Nov; 163(5):1461-1469. PubMed ID: 36137844
[TBL] [Abstract][Full Text] [Related]
5. Celiac disease: how complicated can it get?
Tjon JM; van Bergen J; Koning F
Immunogenetics; 2010 Oct; 62(10):641-51. PubMed ID: 20661732
[TBL] [Abstract][Full Text] [Related]
6. Advances in Nonresponsive and Refractory Celiac Disease.
Malamut G; Soderquist CR; Bhagat G; Cerf-Bensussan N
Gastroenterology; 2024 Mar; ():. PubMed ID: 38556189
[TBL] [Abstract][Full Text] [Related]
7. [Refractory celiac disease].
Iwańczak F; Iwańczak B
Pol Merkur Lekarski; 2013 Jul; 35(205):47-50. PubMed ID: 23984606
[TBL] [Abstract][Full Text] [Related]
8. Management of celiac disease in daily clinical practice.
Elli L; Ferretti F; Orlando S; Vecchi M; Monguzzi E; Roncoroni L; Schuppan D
Eur J Intern Med; 2019 Mar; 61():15-24. PubMed ID: 30528262
[TBL] [Abstract][Full Text] [Related]
9. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
[TBL] [Abstract][Full Text] [Related]
10. The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet.
McAllister CS; Kagnoff MF
Semin Immunopathol; 2012 Jul; 34(4):581-600. PubMed ID: 22674144
[TBL] [Abstract][Full Text] [Related]
11. [Adult Celiac Disease].
Many N; Biedermann L
Praxis (Bern 1994); 2016 Jul; 105(14):803-10; quiz 809-12. PubMed ID: 27381303
[TBL] [Abstract][Full Text] [Related]
12. Sampling of proximal and distal duodenal biopsies in the diagnosis and monitoring of celiac disease.
Caruso R; Marafini I; Del Vecchio Blanco G; Fina D; Paoluzi OA; Colantoni A; Sedda S; Pallone F; Monteleone G
Dig Liver Dis; 2014 Apr; 46(4):323-9. PubMed ID: 24394601
[TBL] [Abstract][Full Text] [Related]
13. Current pharmacological approaches and potential future therapies for Celiac disease.
Kulkarni A; Patel S; Khanna D; Parmar MS
Eur J Pharmacol; 2021 Oct; 909():174434. PubMed ID: 34418405
[TBL] [Abstract][Full Text] [Related]
14. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.
Kaukinen K; Peräaho M; Collin P; Partanen J; Woolley N; Kaartinen T; Nuutinen T; Halttunen T; Mäki M; Korponay-Szabo I
Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509
[TBL] [Abstract][Full Text] [Related]
15. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
Høydahl LS; Richter L; Frick R; Snir O; Gunnarsen KS; Landsverk OJB; Iversen R; Jeliazkov JR; Gray JJ; Bergseng E; Foss S; Qiao SW; Lundin KEA; Jahnsen J; Jahnsen FL; Sandlie I; Sollid LM; Løset GÅ
Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
[TBL] [Abstract][Full Text] [Related]
16. Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease.
Koskinen O; Collin P; Korponay-Szabo I; Salmi T; Iltanen S; Haimila K; Partanen J; Mäki M; Kaukinen K
J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):436-42. PubMed ID: 18852635
[TBL] [Abstract][Full Text] [Related]
17. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease.
Kaukinen K; Sulkanen S; Mäki M; Collin P
Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):311-5. PubMed ID: 11953698
[TBL] [Abstract][Full Text] [Related]
18. Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.
Tack GJ; van de Water JM; Bruins MJ; Kooy-Winkelaar EM; van Bergen J; Bonnet P; Vreugdenhil AC; Korponay-Szabo I; Edens L; von Blomberg BM; Schreurs MW; Mulder CJ; Koning F
World J Gastroenterol; 2013 Sep; 19(35):5837-47. PubMed ID: 24124328
[TBL] [Abstract][Full Text] [Related]
19. Celiac disease: prevention and treatment.
Selimoğlu MA; Karabiber H
J Clin Gastroenterol; 2010 Jan; 44(1):4-8. PubMed ID: 20027009
[TBL] [Abstract][Full Text] [Related]
20. Celiac disease: risk assessment, diagnosis, and monitoring.
Setty M; Hormaza L; Guandalini S
Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
